• 1
    Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T. 2004. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38:29182926.
  • 2
    Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. 2008. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 43:363380.
  • 3
    Choubert JM, Ruel SM, Esperanza M, Budzinski H, Miege C, Lagarrigue C, Coquery M. 2011. Limiting the emissions of micro-pollutants: what efficiency can we expect from wastewater treatment plants? Water Sci Technol 63:5765.
  • 4
    Miège C, Choubert JM, Ribeiro L, Eusèbe M, Coquery M. 2009. Fate of pharmaceuticals and personal care products in wastewater treatment plants—Conception of a database and first results. Environ Pollut 157:17211726.
  • 5
    Musolff A, Leschik S, Moder M, Strauch G, Reinstorf F, Schirmer M. 2009. Temporal and spatial patterns of micropollutants in urban receiving waters. Environ Pollut 157:30693077.
  • 6
    Kumar V, Chakraborty A, Viswanath G, Roy P. 2007. Androgenic endocrine disruptors in wastewater treatment plant effluents in India: Their influence on reproductive processes and systemic toxicity in male rats. Toxicol Appl Pharmacol 226:6073.
  • 7
    Nelson J, Bishay F, Van Roodselaar A, Ikonomou M, Law FCP. 2007. The use of in vitro bioassays to quantify endocrine disrupting chemicals in municipal wastewater treatment plant effluents. Sci Total Environ 374:8090.
  • 8
    Mills GA, Vrana B, Allan I, Alvarez DA, Huckins JN, Greenwood R. 2007. Trends in monitoring pharmaceuticals and personal-care products in the aquatic environment by use of passive sampling devices. Anal Bioanal Chem 387:11531157.
  • 9
    Stuer-Lauridsen F. 2005. Review of passive accumulation devices for monitoring organic micropollutants in the aquatic environment. Environ Pollut 136:503524.
  • 10
    Alvarez DA, Petty JD, Huckins JN, Jones-Lepp TL, Getting DT, Goddard JP, Manahan SE. 2004. Development of a passive, in situ, integrative sampler for hydrophilic organic contaminants in aquatic environments. Environ Toxicol Chem 23:16401648.
  • 11
    MacLeod SL, McClure EL, Wong CS. 2007. Laboratory calibration and field deployment of the polar organic chemical integrative sampler for pharmaceuticals and personal care products in wastewater and surface water. Environ Toxicol Chem 26:25172529.
  • 12
    Zhang Z, Hibberd A, Zhou JL. 2008. Analysis of emerging contaminants in sewage effluent and river water: comparison between spot and passive sampling. Anal Chim Acta 607:3744.
  • 13
    Bartelt-Hunt SL, Snow DD, Damon T, Shockley J, Hoagland K. 2009. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. Environ Pollut 157:786791.
  • 14
    Grabic R, Jurcikova J, Tomsejova S, Ocelka T, Halirova J, Hypr D, Kodes V. 2010. Passive sampling methods for monitoring endocrine disruptors in the Svratka and Svitava Rivers in the Czech Republic. Environ Toxicol Chem 29:550555.
  • 15
    Vermeirssen ELM, Körner O, Schönenberger R, Suter MJF, Burkhardt-Holm P. 2005. Characterization of environmental estrogens in river water using a three pronged approach: Active and passive water sampling and the analysis of accumulated estrogens in the bile of caged fish. Environ Sci Technol 39:81918198.
  • 16
    Mazella N, Lissalde S, Moreira S, Delmas F, Mazellier P, Huckins J. 2010. Evaluation of the use of performance reference compounds in an oasis-HLB adsorbent based passive sampler for improving water concentration estimates of polar herbicides in freshwater. Environ Sci Technol 44:17131719.
  • 17
    Togola A, Budzinski H. 2007. Development of polar organic integrative samplers for analysis of pharmaceuticals in aquatic systems. Anal Chem 79:67346741.
  • 18
    Arditsoglou A, Voutsa D. 2008. Passive sampling of selected endocrine disrupting compounds using polar organic chemical integrative samplers. Environ Pollut 156:316324.
  • 19
    Li H, Helm PA, Metcalfe CD. 2010. Sampling in the Great Lakes for pharmaceuticals, personal care products, and endocrine-disrupting substances using the passive polar organic chemical integrative sampler. Environ Toxicol Chem 29:751762.
  • 20
    Bartelt-Hunt SL, Snow DD, Damon-Powell T, Brown DL, Prasai G, Schwarz M, Kolok AS. 2011. Quantitative evaluation of laboratory uptake rates for pesticides, pharmaceuticals, and steroid hormones using POCIS. Environ Toxicol Chem 30:14121420.
  • 21
    Huckins JN, Petty JD, Booij K. 2006. Monitors of organic chemicals in the environment. Springer, New York, NY, USA.
  • 22
    Gabet-Giraud V, Miège C, Choubert JM, Martin Ruel S, Coquery M. 2010. Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants. Sci Total Environ 408:42574269.
  • 23
    Scheurer M, Ramil M, Metcalfe CD, Groh S, Ternes TA. 2010. The challenge of analyzing beta-blocker drugs in sludge and wastewater. Anal Bioanal Chem 396:845856.
  • 24
    Gross-Sorokin MY, Roast SD, Brighty GC. 2006. Assessment of feminization of male fish in English rivers by the environment agency of England and Wales. Environ Health Perspect 114:147151.
  • 25
    Miège C, Bados P, Brosse C, Coquery M. 2009. Method validation for the analysis of estrogens (including conjugated compounds) in aqueous matrices. Trends Anal Chem 28:237244.